Gileadʹs antiviral drug remdesivir (Veklury, 1) was approved by the FDA on May 1st for emergency use against coronavirus disease-2019 (COVID-19) after just a one-day review. Now the onerous task falls upon Gilead to make enough of the drug to supply doctors and...
Understanding the Complexities of Antibody-Drug Conjugate (ADC) Development Antibody-drug conjugates (ADCs) are at the forefront of targeted cancer therapies, offering a powerful combination of monoclonal antibody specificity and cytotoxic drug potency. However, ADC...